News
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
A University of Dundee spin-out has formed a new company dedicated to developing new obesity therapies that avoid the muscle ...
But it’s taking neither seriously. Despite the fact that more than 64% of people in the UK are either overweight or obese our ...
A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results